What is ZYBT's current stock price?

ZYBT (Zhengye Biotechnology Holding Limited) is currently trading at $0.81 with a market cap of $38.4M.

What sector is Zhengye Biotechnology Holding Limited in?

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

InvestLog

ZYBT Zhengye Biotechnology Holding Limited

Healthcare

$0.81+0.00%OpenMarket Cap: $38.4M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.00

P/S

2.40

EV/EBITDA

-7.15

DCF Value

$1.07

FCF Yield

0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

20.5%

Operating Margin

-58.7%

Net Margin

-60.0%

ROE

-26.1%

ROA

-16.0%

ROIC

-17.9%

Financials

View All

Period	Revenue	Net Income	EPS
FY null	$116.4M	$-69.8M	$—
FY null	$186.4M	$11.3M	$—
FY null	$211.7M	$31.5M	$—
FY null	$260.3M	$46.7M	$—

Trading Activity

Insider Trades

View All

Li Guohan (nmn)director:

SellFri Apr 24

Hu Qiyidirector:

SellFri Apr 24

Sun Wenhuadirector:

SellWed Mar 18

Liu Zhongyaoofficer

SellWed Mar 18

Lian Weiofficer

SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

-2.45

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Peers